On December 24th, BeiGene announced that the stock code of its American Depositary Shares traded on NASDAQ will be changed from "BGNE" to "ONC", effective from January 2, 2025, to demonstrate the company's firm commitment to providing innovative cancer drugs worldwide.
The stock code and securities abbreviation of the company on the Shanghai Stock Exchange and the stock code and securities abbreviation of The Stock Exchange of Hong Kong Limited remain unchanged.